Supplying the newest API's & rarest Molecules for your R&D needsSupplying the newest API's & rarest Molecules for your R&D needs
  Home Products Company Profile Compounding Products Events Resources Blog News Contact Us

Featured Products

LGM Pharma is proud to present to you our new line of "Gliptin" Active Pharmaceutical Ingredients:

Product Name: CAS#:
Alogliptin 850649-62-6
Linagliptin 668270-12-0
Saxagliptin 361442-04-8
Sitagliptin Phosphate (monohydrate) 654671-77-9
Sitagliptin Phosphate (anhydrous) 654671-78-0
Vildagliptin 274901-16-5

This small group of hypoglycemic API's (anti-diabetic drugs), nicknamed "gliptins", are available for prompt delievery. Their longer name is Dipeptidyl peptidase-4 inhibitors or DPP-4 inhibitors.

Read our Gliptins blog article discussing the report published last month in Medpage Today >

LGM Pharma is committed to providing full sourcing options and support for the widest range of rare and new APIs in the R&D community.

Lansoprazole outruns Ranitidine in the long term battle of GERD treatment

Relatively new drugs (such as the proton pump inhibitor Lansoprazole CAS# 103577-45-3) have a greater treatment role in certain disorders and diseases than what they were initially approved for. In light of these developments, LGM Pharma has not only kept its focus on the market for new studies, but it has also been a consistent supplier of Lansoprazole CAS# 103577-45-3. By lending their hand as a responsive supplier, the company believes that it has helped to invigorate similar research efforts by pharmaceutical organizations worldwide...

Read more on our blog >


Recent Blog Posts

LGM Pharma supplies Ivabradine, the novel drug that cuts down mortality rates
Posted on: 10/18/11

A study presented at the European Society of Cardiology (ESC) Congress 2010 gives promising results to patients suffering from heart failure with tachycardia...
More >

Iloprost favors the quitters in the battle against lung cancer
Posted on: 10/5/11

After taking biopsies of former smokers' lungs, the study reported significant reductions in lesions. However, the biopsies of current smokers showed no changes...
More >

Methimazole provides a good alternative to surgery and radiation in Grave's disease therapy
Posted on: 10/20/11

A study published in the European Journal of Endocrinology that compared the long term effects of 10 year therapy with methimazole with radioactive iodine therapy found...
More >


Disclaimer: Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

6400 Congress Ave., Suite 1400, Boca Raton FL 33487 • Phone: (561) 981-9994 • Fax: (561) 892-0580 • Sitemap
Copyright © 2011 LGM Pharma, LLC. All Rights Reserved | Privacy Policy